VSports最新版本 - Novel functions for NFκB: inhibition of bone formation
- PMID: 20703218
- PMCID: PMC3078572
- DOI: 10.1038/nrrheum.2010.133
Novel functions for NFκB: inhibition of bone formation (V体育平台登录)
V体育2025版 - Abstract
NFκB is a family of transcription factors involved in immunity and the normal functioning of many tissues VSports手机版. It has been well studied in osteoclasts, and new data indicate an important role for NFκB in the negative regulation of bone formation. In this article, we discuss how NFκB activation affects osteoblast function and bone formation. In particular, we describe how reduced NFκB activity in osteoblasts results in an increase in bone formation via enhanced c-Jun N-terminal kinase (JNK) activity, which regulates FOSL1 (also known as Fra1) expression. Furthermore, we discuss how estrogen and NFκB crosstalk in osteoblasts acts to oppositely regulate bone formation. Future NFκB-targeting treatments for osteoporosis, rheumatoid arthritis and other inflammatory bone diseases could lead to increased bone formation concurrent with decreased bone resorption. .
Conflict of interest statement
The authors declare no competing interests.
Figures


References
-
- Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell. 2002;109 (Suppl):S81–S96. - PubMed
-
- Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. Inflammation and NF-κB in Alzheimer’s disease and diabetes. J Alzheimers Dis. 2009;16:809–821. - PubMed
-
- Geusens P. Emerging treatments for postmenopausal osteoporosis—focus on denosumab. Clin Interv Aging. 2009;4:241–250. - V体育平台登录 - PMC - PubMed
-
- Jimi E, Ghosh S. Role of nuclear factor-κB in the immune system and bone. Immunol Rev. 2005;208:80–87. - PubMed
-
- Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003;305:211–214. - PubMed
Publication types
- "VSports最新版本" Actions
MeSH terms
- "VSports手机版" Actions
- Actions (VSports最新版本)
- "VSports" Actions
- Actions (V体育平台登录)
- V体育安卓版 - Actions
- "V体育2025版" Actions
- "V体育安卓版" Actions
- "V体育ios版" Actions
- Actions (V体育ios版)
- "VSports app下载" Actions
- V体育ios版 - Actions
- V体育平台登录 - Actions
- Actions (VSports app下载)
- Actions (VSports最新版本)
- "V体育官网入口" Actions
Substances
- VSports在线直播 - Actions
- Actions (V体育平台登录)
- "V体育官网入口" Actions
- V体育官网入口 - Actions
Grants and funding
- R01 CA100849/CA/NCI NIH HHS/United States (VSports手机版)
- DE17684/DE/NIDCR NIH HHS/United States
- DE019412/DE/NIDCR NIH HHS/United States
- "VSports注册入口" K12 HD001400/HD/NICHD NIH HHS/United States
- CA100849/CA/NCI NIH HHS/United States
- R01 DE017684/DE/NIDCR NIH HHS/United States
- K22 CA137168/CA/NCI NIH HHS/United States
- R01 DE016513/DE/NIDCR NIH HHS/United States
- R01 DE019412/DE/NIDCR NIH HHS/United States (V体育官网入口)
- "VSports最新版本" K12 HD001400‑08/HD/NICHD NIH HHS/United States
- DE016513/DE/NIDCR NIH HHS/United States
- "V体育官网入口" DE13848/DE/NIDCR NIH HHS/United States
- R37 DE013848/DE/NIDCR NIH HHS/United States
- R01 DE013848/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
"V体育ios版" Research Materials
Miscellaneous